Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Maria L. Agostini · SciRah

Researcher profile · Semantic Scholar

Maria L. Agostini

Share profile

Maria L. Agostini — researcher profile on SciRah

h-index: 16
Works: 20
Citations: 5,011

Most-cited papers

Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini, Erica L. Andres, A. Sims, R. Graham +13 more
2018mBio1,328 citations Open access
Semantic Scholar
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice
T. Sheahan, A. Sims, Shuntai Zhou, R. Graham +24 more
2020Science Translational Medicine1,006 citations Open access
Semantic Scholar
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape
Tyler N. Starr, N. Czudnochowski, Zhuoming Liu, F. Zatta +53 more
2021Nature485 citations Open access
Semantic Scholar
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS-CoV-2 RNA Polymerase in Mice
Andrea J. Pruijssers, Amelia S. George, A. Schäfer, S. Leist +25 more
2020Cell Reports448 citations Open access
Semantic Scholar
SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern
M. McCallum, Jessica Bassi, A. De Marco, Alex Chen +28 more
2021Science359 citations Open access
Semantic Scholar
Small-Molecule Antiviral β-d-N4-Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance
Maria L. Agostini, Andrea J. Pruijssers, J. Chappell, J. Gribble +12 more
2019Journal of Virology286 citations Open access
Semantic Scholar
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
F. Lempp, L. Soriaga, Martin Montiel-Ruiz, F. Benigni +22 more
2021Nature273 citations
Semantic Scholar
The coronavirus proofreading exoribonuclease mediates extensive viral recombination
J. Gribble, Andrea J. Pruijssers, Maria L. Agostini, Jordan Anderson-Daniels +5 more
2020bioRxiv247 citations Open access
Semantic Scholar
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and in vivo activity against SARS-CoV-2
A. Cathcart, C. Havenar-Daughton, F. Lempp, Da Ma +37 more
2022bioRxiv220 citations Open access
Semantic Scholar
SARS-CoV-2 immune evasion by variant B.1.427/B.1.429
M. McCallum, Jessica Bassi, A. De Marco, Alex Chen +27 more
2021bioRxiv134 citations Open access
Semantic Scholar
Remdesivir potently inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice
Andrea J. Pruijssers, Amelia S. George, A. Schäfer, S. Leist +25 more
2020bioRxiv61 citations Open access
Semantic Scholar
An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 and multiple endemic, epidemic and bat coronavirus
T. Sheahan, A. Sims, Shuntai Zhou, R. Graham +20 more
2020bioRxiv48 citations Open access
Semantic Scholar
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
Tyler N. Starr, N. Czudnochowski, F. Zatta, Young-Jun Park +42 more
2021bioRxiv30 citations Open access
Semantic Scholar
A mutation in the coronavirus nsp13-helicase impairs enzymatic activity and confers partial remdesivir resistance
Samantha L. Grimes, Y. J. Choi, Anoosha Banerjee, G. Small +9 more
2023mBio25 citations Open access
Semantic Scholar
Membrane lectins enhance SARS-CoV-2 infection and influence the neutralizing activity of different classes of antibodies
F. Lempp, L. Soriaga, Martin Montiel-Ruiz, F. Benigni +18 more
2021bioRxiv22 citations Open access
Semantic Scholar
Fitness Barriers Limit Reversion of a Proofreading-Deficient Coronavirus
Kevin W Graepel, Maria L. Agostini, Xiao-Tao Lu, Nicole R. Sexton +1 more
2019Journal of Virology17 citations Open access
Semantic Scholar
Intramuscular vs Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Noninferiority Clinical Trial
A. Shapiro, E. Sarkis, Jude Acloque, A. Free +24 more
2023Open Forum Infectious Diseases16 citations Open access
Semantic Scholar
1150. Resistance Analysis in the COMET-TAIL Study: Participants with Mild-to-Moderate COVID-19 Treated with Intramuscular or Intravenous Sotrovimab
Maria L. Agostini, G. Schnell, J. di Iulio, A. Kohli +9 more
2022Open Forum Infectious Diseases6 citations Open access
Semantic Scholar
Intramuscular Versus Intravenous SARS-CoV-2 Neutralizing Antibody Sotrovimab for Treatment of COVID-19 (COMET-TAIL): A Randomized Non-inferiority Clinical Trial
A. Shapiro, E. Sarkis, Jude Acloque, A. Free +24 more
2023medRxiv4 citations Open access
Semantic Scholar
The dual function monoclonal antibodies VIR-7831 and VIR-7832 demonstrate potent in vitro and 2 in vivo activity against SARS-CoV-2 3
A. Cathcart, C. Havenar-Daughton, F. Lempp, Daphne Y. Ma +36 more
3 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

M. Denison×9
Invite
M. Denison — researcher profile on SciRah
Xiao-Tao Lu×8
Invite
Xiao-Tao Lu — researcher profile on SciRah
E. Cameroni×8
Invite
E. Cameroni — researcher profile on SciRah
Andrea J. Pruijssers×7
Invite
Andrea J. Pruijssers — researcher profile on SciRah

×7

Invite

J. di Iulio — researcher profile on SciRah

Invite

A. Telenti — researcher profile on SciRah

Invite

H. Virgin — researcher profile on SciRah

Invite

D. Corti — researcher profile on SciRah

Invite

T. Sheahan — researcher profile on SciRah

Invite

R. Baric — researcher profile on SciRah

Invite

D. Pinto — researcher profile on SciRah

Invite

J. Bowen — researcher profile on SciRah